Skip to main content
Émélie Braschi

Émélie Braschi

Physician advisor at the College of Family Physicians of Canada and hospitalist at Élisabeth Bruyère Hospital in Ottawa; MD PhD CCFP

Jun 17, 2026

4:47
So what did you guys find?
4:48
Yeah, so and just from now on, if I use the word Saba, I refer to short-acting beta agonists, so terbutaline or sabutamol.
4:57
So we focused on randomized controlled trials for this question.
5:01
So I'll be talking about the main ones.
5:03
The first question was looking at as-needed predesonide with a combination of beta agonist, so mostly for mineral, but some trials have also used salbutamol, versus Saba, both use PRN.
5:16
Those and the first couple of trials that we talked about enrolled patients with uncontrolled mild asthma.
5:22
So the main one is a trial of about 2,500 adults that had, as I said, uncontrolled mild asthma.

9 MINS LATER

14:22
Yeah, for sure.
4:55
Yeah
4:55
... terbutaline or salbutamol.
4:57
Um, so we focused on randomized control trials for this question, so I'll be talking about the main ones.
5:03
The first questions was looking at as needed budesonide with a combination of a beta agonist, so mostly formoterol, but some trials have also used salbutamol versus, uh, SABA.
5:14
Both used PRN.
5:16
Those, and the first couple of trials that we talk about enrolled patients with uncontrolled mild asthma.
5:23
So the main one is a trial of about 2,500 adults, um, that had, as I said, uncontrolled mild asthma.
9:06
But there, there's also s- a little bit more information as, uh, uh-

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.